Search Results - "Cassol, Chiara"

The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak by Sambataro, Gianluca, Giuffrè, Mauro, Sambataro, Domenico, Palermo, Andrea, Vignigni, Giovanna, Cesareo, Roberto, Crimi, Nunzio, Torrisi, Sebastiano Emanuele, Vancheri, Carlo, Malatino, Lorenzo, Colaci, Michele, Del Papa, Nicoletta, Pignataro, Francesca, Roman-Pognuz, Erik, Fabbiani, Massimiliano, Montagnani, Francesca, Cassol, Chiara, Cavagna, Lorenzo, Zuccaro, Valentina, Zerbato, Verena, Maurel, Cristina, Luzzati, Roberto, Di Bella, Stefano

“…This study aims to assess the peripheral blood cell count "signature" of Severe Acute Respiratory Syndrome-Coronavirus 2 (SARS-CoV-2) to discriminate promptly…”
Get full text

How to tailor recommendations on the treatment of multi-drug resistant Gram-negative infections at country level integrating antibiotic stewardship principles within the GRADE-ADOLOPMENT framework by Carrara, Elena, Grossi, Paolo Antonio, Gori, Andrea, Lambertenghi, Lorenza, Antonelli, Massimo, Lombardi, Andrea, Bongiovanni, Filippo, Magrini, Nicola, Manfredi, Carlo, Stefani, Stefania, Tumbarello, Mario, Tacconelli, Evelina

“…Promoting the optimal use of antibiotics through evidence-based recommendations should be regarded as a crucial step in the global fight against antimicrobial…”
Get full text

Trend over time of HIV‐1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) and their drivers: A cohort study from Antiviral Response Cohort Analysis (ARCA) by Rancan, Ilaria, Cassol, Chiara, Graziani, Lucia, Tilli, Marta, Malcontenti, Costanza, Russo, Chiara, Bottanelli, Martina, Bracchitta, Fiorenza, Papaioannu, Rebecka, Labate, Laura, Mora, Sara, Bezenchek, Antonia, Shallvari, Adrian, Di Biagio, Antonio, Rossetti, Barbara

“…The rise of HIV‐1 drug resistance to nonnucleoside reverse transcriptase inhibitors (NNRTIs) threatens the long‐term success of NNRTI‐based therapies. Our…”
Get full text

Peripheral biomarkers' panel for severe COVID‐19 patients by d'Alessandro, Miriana, Bergantini, Laura, Cameli, Paolo, Curatola, Giuseppe, Remediani, Lorenzo, Sestini, Piersante, Bargagli, Elena

Get full text

Could Long-Acting Cabotegravir-Rilpivirine Be the Future for All People Living with HIV? Response Based on Genotype Resistance Test from a Multicenter Italian Cohort by De Vito, Andrea, Botta, Annarita, Berruti, Marco, Castelli, Valeria, Lai, Vincenzo, Cassol, Chiara, Lanari, Alessandro, Stella, Giulia, Shallvari, Adrian, Bezenchek, Antonia, Di Biagio, Antonio

“…Long-acting (LA) formulations have been designed to improve the quality of life of people with HIV (PWH) by maintaining virologic suppression. However,…”
Get full text

Prevalence of resistance-associated substitutions to NS3, NS5A and NS5B inhibitors at DAA-failure in hepatitis C virus in Italy from 2015 to 2019 by Rossetti, Barbara, Paglicci, Lorenzo, Di Maio, Velia C, Cassol, Chiara, Barbaliscia, Silvia, Paolucci, Stefania, Bruzzone, Bianca, Coppola, Nicola, Montagnani, Francesca, Micheli, Valeria, Monno, Laura, Zanelli, Giacomo, Santantonio, Teresa, Cuomo, Nunzia, Caudai, Cinzia, Zazzi, Maurizio, Ceccherini-Silberstein, Francesca, On Behalf Of The Hcv Virology Italian Resistance Network Vironet, C

Get full text